The Polymorphic Drug Substances of the European Pharmacopoeia. Part 9. Physicochemical Properties and Crystal Structure of Acetazolamide Crystal Forms
- 1 March 1997
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 86 (3) , 352-358
- https://doi.org/10.1021/js960264c
Abstract
The crystal structure of acetazolamide modification I (mod. I) was determined, and its differences compared with the already known crystal structure of the triclinic modification II (mod. II) are discussed. The monoclinic mod. I crystallizes in space group P2(1)/n with four molecules in the unit cell: a = 4.7674, b = 21.956, and c = 8.186 A, beta = 104.23 degrees. In both modifications, the molecules form hydrogen-bonded centrosymmetric dimers. The two modifications differ distinctly in the spatial arrangement of these pairs and in the hydrogen bonds formed between them. The thermodynamic relationship between the two modifications is demonstrated by a semischematic energy/temperature diagram, based on the results of thermal analysis and solubility experiments. Mod. II is the thermodynamically stable modification at 20 degrees C and enantiotropically related to mod. I. The thermodynamic transition point lies between 120 and 148 degrees C. The solid-state properties of acetazolamide are mainly directed by the strong intermolecular hydrogen bond forces. Thus, the metastable mod. I exhibits a higher density than mod. II and a very high kinetic stability at 20 degrees C. Both modifications can be crystallized from water and the solubility differences are very small, so, in addition to mod. II, the metastable but extremely resistant mod. I is suggested to be suitable for use in solid pharmaceutical formulations.Keywords
This publication has 19 references indexed in Scilit:
- Muster aus H‐Brücken: ihre Funktionalität und ihre graphentheoretische Analyse in KristallenAngewandte Chemie, 1995
- The x-ray characterization of 12 diureticsJournal of Chemical & Engineering Data, 1992
- Development of Oral Liquid Dosage Forms of AcetazolamideJournal of Pharmaceutical Sciences, 1990
- Graph-set analysis of hydrogen-bond patterns in organic crystalsActa crystallographica Section B, Structural science, crystal engineering and materials, 1990
- Conformational Polymorphism VI: The Crystal and Molecular Structures of Form II, Form 111, and Form V of 4-Amino-N-2-pyridinylbenzenesulfonamide (Sulfapyridine)Journal of Pharmaceutical Sciences, 1985
- Physico-chemical properties and isothermal transition of acetazolamide polymorphs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Crystal and molecular structure of acetazolamide (5-acetamido-1,3,4-thiadiazole-2-sulphonamide), a potent inhibitor of carbonic anhydraseJournal of the Chemical Society, Perkin Transactions 2, 1974
- Polymorphie und Mischkristallbildung bei Sulfonamiden und verwandten VerbindungenMicrochimica Acta, 1969
- 1,3,4-Thiadiazole- and Thiadiazolinesulfonamides as Carbonic Anhydrase Inhibitors. Synthesis and Structural StudiesJournal of the American Chemical Society, 1956
- Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors1Journal of the American Chemical Society, 1950